Page 8 - புனே அடிப்படையிலானது தேசிய நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புனே அடிப்படையிலானது தேசிய நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புனே அடிப்படையிலானது தேசிய நிறுவனம் Today - Breaking & Trending Today

Experience of past vaccinations can be of help

1342
Unprecedented: The Central and state governments are grappling with the gigantic task of administering the Covid vaccines. PTI
Parsa Venkateshwar Rao Jr
Senior Journalist
The sense of relief and euphoria felt by the people and the Modi government over the availability of Covid-19 vaccines at the beginning of the new year is understandable after the long lockdown of 2020 and the mental and physical stress it caused all round. The Central and state governments are now grappling with the gigantic task of administering the vaccines manufactured by Pune-based Serum Institute of India (SII) and Hyderabad-based Bharat Biotech. There are going to be hurdles and glitches as the operation unfolds, but the sense of helplessness is gone. With the vaccines at hand, the hospitals and the frontline health workers with auxiliary support from the administration at all levels can succeed in immunising a large section of the population during the year. ....

United Kingdom , Tamil Nadu , Himachal Pradesh , Parsa Venkateshwar Rao Jr , Narendra Modi , Chandrakant Lahariya , Edward Jenner , University Of Oxford , National Institute Of Virology , Oxford Institute , Immunisation Programme , Central Research Institute In Kasauli , Pasteur Institute Of Southern India , Indian Journal Of Medical Research , Serum Institute Of India , Parsa Venkateshwar Rao , Pune Based Serum Institute , Hyderabad Based Bharat , Drugs Controller General , Prime Minister Narendra Modi , Severe Acute Respiratory Syndrome , Bharat Biotech , Pune Based National Institute , Indian Journal , Medical Research , British Army ,

India Today reporter Kumar Abhishek gets second dose of Bharat Biotech's Covaxin as part of Phase 3 trials

India Today reporter Kumar Abhishek gets second dose of Bharat Biotech s Covaxin as part of Phase 3
India Today reporter Kumar Abhishek gets second dose of Bharat Biotech s Covaxin as part of Phase 3 trials
India Today TV s Kumar Abhishek was the first journalist from Uttar Pradesh who opted for the clinical trials of Bharat Biotech s Covid-19 vaccine Covaxin. He received the first dose in Kanpur on December 11.
advertisement
UPDATED: January 10, 2021 17:04 IST
India Today TV reporter Kumar Abhishek receiving a shot of Bharat BioTech s Covaxin during its Phase 3 trials in Kanpur
Kumar Abhishek, India Today TV reporter who is participating in Phase 3 of the clinical trials of Bharat Biotech s Covaxin, received the second dose of the Covid-19 vaccine on Saturday. After he was administered two doses of the indigenous coronavirus vaccine within a span of 28 days, Kumar Abhishek is now being kept under observation. ....

Uttar Pradesh , Kumar Abhishek , National Institute Of Virology , University Of Oxford , Indian Council Of Medical Research , Serum Institute Of India , India Today , Bharat Biotech , Hyderabad Based Bharat Biotech , Indian Council , Medical Research , Pune Based National Institute , Pune Based Serum Institute , Kumar Abhishek India Today , Phase 3 Clinical Trials Of Bharat Biotech Covaxin , Second Dose Of Covid 19 Vaccine , Indigenous Coronavirus Vaccine , Trial Of Covid 19 Vaccine , Covaxin Covishield Vaccines , உத்தர் பிரதேஷ் , குமார் அபிஷேக் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , சீரம் நிறுவனம் ஆஃப் இந்தியா , இந்தியா இன்று ,

Coronavirus | Tripura lists health workers for COVID-19 vaccine

Image for representative purposes only
| Photo Credit: PTI
Minister says 44,521 health workers will be administered the vaccine when it’s approved for use
The Tripura government listed 44,521 health workers to administer them COVID-19 vaccine whenever it will be approved for use, senior State Minister Ratan Lal Nath said. He said the first batch of people would receive the vaccine at 2,263 centres across the State.
The seniormost Minister in the State Cabinet said that 145 cold storage facilities spread over eight districts had been identified to stock-up the vaccine, while the central storage will be in Agartala.
The Minister spoke on the latest COVID-19 situation and the State’s response to it. He said one U.K. returned person had tested positive for the coronavirus. ....

Biplab Kumar Deb , Lal Nath , National Institute Of Virology , Health Department , Covid Care Centre , State Minister Ratan Lal Nath , State Cabinet , Pune Based National Institute , Standard Operating Procedure , Ratan Lal Nath , Chief Minister Biplab Kumar Deb , Chief Minister , பிப்லாப் குமார் டெப் , லால் நாத் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , ஆரோக்கியம் துறை , நிலை அமைச்சர் ரட்ன் லால் நாத் , நிலை மந்திரி சபை , புனே அடிப்படையிலானது தேசிய நிறுவனம் , தரநிலை இயங்குகிறது ப்ரொஸீஜர் , ரட்ன் லால் நாத் , தலைமை அமைச்சர் பிப்லாப் குமார் டெப் , தலைமை அமைச்சர் ,

New strain unlikely to reduce Covid vaccine efficacy, say experts

Pune-based National Institute of Virology is reportedly monitoring the new strains from other countries closely and is said to submit its data to the Indian Council of Medical Research soon. ....

United Kingdom , Giridhara Babu , Chetana Belagere , Ugur Sahin , Union Health , National Institute Of Virology , Karnataka Health , Indian Council Of Medical Research , News Service , Health Minister Dr Harsh Vardhan , Health Minister Drk Sudhakar , Pune Based National Institute , Indian Council , Medical Research , Anant Bhan , Covid 19 , Covid Vaccine , ஒன்றுபட்டது கிஂக்டம் , தொழிற்சங்கம் ஆரோக்கியம் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , கர்நாடகா ஆரோக்கியம் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , செய்தி சேவை , ஆரோக்கியம் அமைச்சர் டாக்டர் கடுமையான வர்தன் , ஆரோக்கியம் அமைச்சர் டர்க் சுதாகர் , புனே அடிப்படையிலானது தேசிய நிறுவனம் ,

Assam under 'panic attack' following detection of COVID+ person who returned from England

Assam under panic attack following detection of COVID+ person who returned from England
Assam has been under a panic attack following the detection of COVID-19 in a person who returned from England recently.
STAFF REPORTER
GUWAHATI: Assam has been under a panic attack following the detection of COVID-19 in a person who returned from England recently. The panic has stemmed from the outbreak of a mutated variant of Coronavirus detected in Britain. However, State Health Minister Himanta Biswa Sarma said that there s no fresh wave of the virus.
Addressing the media here on Friday, Health Minister Himanta Biswa Sarma said, A person who has returned to the State from Britain tested COVID-19 positive. To ascertain if the virus is the mutated variant that wreaked havoc in Britain, the sample of the ....

Uttar Pradesh , United Kingdom , Himanta Biswa Sarma , National Institute Of Biologicals , State Health Minister Himanta , Biswa Sarma , Health Minister Himanta Biswa Sarma , Pune Based National Institute , Health Minister , New Year , உத்தர் பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , ஹீமந்த பிஸ்வா சர்மா , தேசிய நிறுவனம் ஆஃப் உயிரியல் , நிலை ஆரோக்கியம் அமைச்சர் ஹீமந்த , பிஸ்வா சர்மா , ஆரோக்கியம் அமைச்சர் ஹீமந்த பிஸ்வா சர்மா , புனே அடிப்படையிலானது தேசிய நிறுவனம் , ஆரோக்கியம் அமைச்சர் , புதியது ஆண்டு ,